 | • レポートコード：GIR-107A14584 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、92ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、グルコシルセラミダーゼのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。グルコシルセラミダーゼの種類別市場規模（AVRRD-02、 LTI-291、 NCGC-607、 Pcgin、 その他）、用途別市場規模（遺伝性疾患、ゴーシェ病、パーキンソン病、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・グルコシルセラミダーゼの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Amicus Therapeutics, Inc.、Bioorganic Research and Services S.A.、greenovation Biotech GmbH、JCR Pharmaceuticals Co., Ltd.、Pharming Group N.V.、Protalix BioTherapeutics, Inc.、Takeda、The International Biotechnology Center (IBC) Generium ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：AVRRD-02、 LTI-291、 NCGC-607、 Pcgin、 その他 ・用途別分析2016年-2026年：遺伝性疾患、ゴーシェ病、パーキンソン病、その他 ・グルコシルセラミダーゼの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・グルコシルセラミダーゼのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・グルコシルセラミダーゼのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・グルコシルセラミダーゼの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・グルコシルセラミダーゼの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Glucosylceramidase market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Glucosylceramidase size is estimated to be xx million in 2021 from USD xx million in 2020, with a change of XX% between 2020 and 2021. The global Glucosylceramidase market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Glucosylceramidase market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
AVRRD-02
LTI-291
NCGC-607
Pcgin
Others
Market segment by Application can be divided into
Genetic Disorders
Gaucher Disease
Parkinson’s Disease
Others
The key market players for global Glucosylceramidase market are listed below:
Amicus Therapeutics, Inc.
Bioorganic Research and Services S.A.
greenovation Biotech GmbH
JCR Pharmaceuticals Co., Ltd.
Pharming Group N.V.
Protalix BioTherapeutics, Inc.
Takeda
The International Biotechnology Center (IBC) Generium
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Glucosylceramidase product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Glucosylceramidase, with price, sales, revenue and global market share of Glucosylceramidase from 2019 to 2021.
Chapter 3, the Glucosylceramidase competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Glucosylceramidase breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Glucosylceramidase market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Glucosylceramidase sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Glucosylceramidase Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Glucosylceramidase Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 AVRRD-02
1.2.3 LTI-291
1.2.4 NCGC-607
1.2.5 Pcgin
1.2.6 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Glucosylceramidase Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Genetic Disorders
1.3.3 Gaucher Disease
1.3.4 Parkinson’s Disease
1.3.5 Others
1.4 Global Glucosylceramidase Market Size & Forecast
1.4.1 Global Glucosylceramidase Sales in Value (2016-2026))
1.4.2 Global Glucosylceramidase Sales in Volume (2016-2026)
1.4.3 Global Glucosylceramidase Price by Type (2016-2026) & (USD/Pcs)
1.5 Global Glucosylceramidase Production Capacity Analysis
1.5.1 Global Glucosylceramidase Total Production Capacity (2016-2026)
1.5.2 Global Glucosylceramidase Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Glucosylceramidase Market Drivers
1.6.2 Glucosylceramidase Market Restraints
1.6.3 Glucosylceramidase Trends Analysis
2 Manufacturers Profiles
2.1 Amicus Therapeutics, Inc.
2.1.1 Amicus Therapeutics, Inc. Details
2.1.2 Amicus Therapeutics, Inc. Major Business
2.1.3 Amicus Therapeutics, Inc. Glucosylceramidase Product and Services
2.1.4 Amicus Therapeutics, Inc. Glucosylceramidase Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 Bioorganic Research and Services S.A.
2.2.1 Bioorganic Research and Services S.A. Details
2.2.2 Bioorganic Research and Services S.A. Major Business
2.2.3 Bioorganic Research and Services S.A. Glucosylceramidase Product and Services
2.2.4 Bioorganic Research and Services S.A. Glucosylceramidase Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 greenovation Biotech GmbH
2.3.1 greenovation Biotech GmbH Details
2.3.2 greenovation Biotech GmbH Major Business
2.3.3 greenovation Biotech GmbH Glucosylceramidase Product and Services
2.3.4 greenovation Biotech GmbH Glucosylceramidase Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 JCR Pharmaceuticals Co., Ltd.
2.4.1 JCR Pharmaceuticals Co., Ltd. Details
2.4.2 JCR Pharmaceuticals Co., Ltd. Major Business
2.4.3 JCR Pharmaceuticals Co., Ltd. Glucosylceramidase Product and Services
2.4.4 JCR Pharmaceuticals Co., Ltd. Glucosylceramidase Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Pharming Group N.V.
2.5.1 Pharming Group N.V. Details
2.5.2 Pharming Group N.V. Major Business
2.5.3 Pharming Group N.V. Glucosylceramidase Product and Services
2.5.4 Pharming Group N.V. Glucosylceramidase Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 Protalix BioTherapeutics, Inc.
2.6.1 Protalix BioTherapeutics, Inc. Details
2.6.2 Protalix BioTherapeutics, Inc. Major Business
2.6.3 Protalix BioTherapeutics, Inc. Glucosylceramidase Product and Services
2.6.4 Protalix BioTherapeutics, Inc. Glucosylceramidase Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 Takeda
2.7.1 Takeda Details
2.7.2 Takeda Major Business
2.7.3 Takeda Glucosylceramidase Product and Services
2.7.4 Takeda Glucosylceramidase Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 The International Biotechnology Center (IBC) Generium
2.8.1 The International Biotechnology Center (IBC) Generium Details
2.8.2 The International Biotechnology Center (IBC) Generium Major Business
2.8.3 The International Biotechnology Center (IBC) Generium Glucosylceramidase Product and Services
2.8.4 The International Biotechnology Center (IBC) Generium Glucosylceramidase Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Glucosylceramidase Sales by Manufacturer
3.1 Global Glucosylceramidase Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Glucosylceramidase Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Glucosylceramidase
3.4 Market Concentration Rate
3.4.1 Top 3 Glucosylceramidase Manufacturer Market Share
3.4.2 Top 6 Glucosylceramidase Manufacturer Market Share
3.5 Global Glucosylceramidase Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Glucosylceramidase Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Glucosylceramidase Market Size by Region
4.1.1 Global Glucosylceramidase Sales in Volume by Region (2016-2026)
4.1.2 Global Glucosylceramidase Revenue by Region (2016-2026)
4.2 North America Glucosylceramidase Revenue (2016-2026)
4.3 Europe Glucosylceramidase Revenue (2016-2026)
4.4 Asia-Pacific Glucosylceramidase Revenue (2016-2026)
4.5 South America Glucosylceramidase Revenue (2016-2026)
4.6 Middle East and Africa Glucosylceramidase Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Glucosylceramidase Sales in Volume by Type (2016-2026)
5.2 Global Glucosylceramidase Revenue by Type (2016-2026)
5.3 Global Glucosylceramidase Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Glucosylceramidase Sales in Volume by Application (2016-2026)
6.2 Global Glucosylceramidase Revenue by Application (2016-2026)
6.3 Global Glucosylceramidase Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Glucosylceramidase Sales by Type (2016-2026)
7.2 North America Glucosylceramidase Sales by Application (2016-2026)
7.3 North America Glucosylceramidase Market Size by Country
7.3.1 North America Glucosylceramidase Sales in Volume by Country (2016-2026)
7.3.2 North America Glucosylceramidase Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Glucosylceramidase Sales by Type (2016-2026)
8.2 Europe Glucosylceramidase Sales by Application (2016-2026)
8.3 Europe Glucosylceramidase Market Size by Country
8.3.1 Europe Glucosylceramidase Sales in Volume by Country (2016-2026)
8.3.2 Europe Glucosylceramidase Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Glucosylceramidase Sales by Type (2016-2026)
9.2 Asia-Pacific Glucosylceramidase Sales by Application (2016-2026)
9.3 Asia-Pacific Glucosylceramidase Market Size by Region
9.3.1 Asia-Pacific Glucosylceramidase Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Glucosylceramidase Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Glucosylceramidase Sales by Type (2016-2026)
10.2 South America Glucosylceramidase Sales by Application (2016-2026)
10.3 South America Glucosylceramidase Market Size by Country
10.3.1 South America Glucosylceramidase Sales in Volume by Country (2016-2026)
10.3.2 South America Glucosylceramidase Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Glucosylceramidase Sales by Type (2016-2026)
11.2 Middle East & Africa Glucosylceramidase Sales by Application (2016-2026)
11.3 Middle East & Africa Glucosylceramidase Market Size by Country
11.3.1 Middle East & Africa Glucosylceramidase Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Glucosylceramidase Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Glucosylceramidase Typical Distributors
12.3 Glucosylceramidase Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Glucosylceramidase Revenue by Type, (USD Million), 2021-2026
Table 2. Global Glucosylceramidase Revenue by Application, (USD Million), 2021-2026
Table 3. Amicus Therapeutics, Inc. Basic Information, Manufacturing Base and Competitors
Table 4. Amicus Therapeutics, Inc. Major Business
Table 5. Amicus Therapeutics, Inc. Glucosylceramidase Product and Services
Table 6. Amicus Therapeutics, Inc. Glucosylceramidase Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Bioorganic Research and Services S.A. Basic Information, Manufacturing Base and Competitors
Table 8. Bioorganic Research and Services S.A. Major Business
Table 9. Bioorganic Research and Services S.A. Glucosylceramidase Product and Services
Table 10. Bioorganic Research and Services S.A. Glucosylceramidase Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. greenovation Biotech GmbH Basic Information, Manufacturing Base and Competitors
Table 12. greenovation Biotech GmbH Major Business
Table 13. greenovation Biotech GmbH Glucosylceramidase Product and Services
Table 14. greenovation Biotech GmbH Glucosylceramidase Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. JCR Pharmaceuticals Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 16. JCR Pharmaceuticals Co., Ltd. Major Business
Table 17. JCR Pharmaceuticals Co., Ltd. Glucosylceramidase Product and Services
Table 18. JCR Pharmaceuticals Co., Ltd. Glucosylceramidase Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Pharming Group N.V. Basic Information, Manufacturing Base and Competitors
Table 20. Pharming Group N.V. Major Business
Table 21. Pharming Group N.V. Glucosylceramidase Product and Services
Table 22. Pharming Group N.V. Glucosylceramidase Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Protalix BioTherapeutics, Inc. Basic Information, Manufacturing Base and Competitors
Table 24. Protalix BioTherapeutics, Inc. Major Business
Table 25. Protalix BioTherapeutics, Inc. Glucosylceramidase Product and Services
Table 26. Protalix BioTherapeutics, Inc. Glucosylceramidase Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Takeda Basic Information, Manufacturing Base and Competitors
Table 28. Takeda Major Business
Table 29. Takeda Glucosylceramidase Product and Services
Table 30. Takeda Glucosylceramidase Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. The International Biotechnology Center (IBC) Generium Basic Information, Manufacturing Base and Competitors
Table 32. The International Biotechnology Center (IBC) Generium Major Business
Table 33. The International Biotechnology Center (IBC) Generium Glucosylceramidase Product and Services
Table 34. The International Biotechnology Center (IBC) Generium Glucosylceramidase Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Global Glucosylceramidase Sales by Manufacturer (2019-2021e) & (K Pcs)
Table 36. Global Glucosylceramidase Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 37. Market Position of Manufacturers in Glucosylceramidase, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 38. Global Glucosylceramidase Production Capacity by Company, (K Pcs): 2020 VS 2021
Table 39. Head Office and Glucosylceramidase Production Site of Key Manufacturer
Table 40. Glucosylceramidase New Entrant and Capacity Expansion Plans
Table 41. Glucosylceramidase Mergers & Acquisitions in the Past Five Years
Table 42. Global Glucosylceramidase Sales by Region (2016-2021e) & (K Pcs)
Table 43. Global Glucosylceramidase Sales by Region (2021-2026) & (K Pcs)
Table 44. Global Glucosylceramidase Revenue by Region (2016-2021e) & (USD Million)
Table 45. Global Glucosylceramidase Revenue by Region (2021-2026) & (USD Million)
Table 46. Global Glucosylceramidase Sales by Type (2016-2021e) & (K Pcs)
Table 47. Global Glucosylceramidase Sales by Type (2021-2026) & (K Pcs)
Table 48. Global Glucosylceramidase Revenue by Type (2016-2021e) & (USD Million)
Table 49. Global Glucosylceramidase Revenue by Type (2021-2026) & (USD Million)
Table 50. Global Glucosylceramidase Price by Type (2016-2021e) & (USD/Pcs)
Table 51. Global Glucosylceramidase Price by Type (2021-2026) & (USD/Pcs)
Table 52. Global Glucosylceramidase Sales by Application (2016-2021e) & (K Pcs)
Table 53. Global Glucosylceramidase Sales by Application (2021-2026) & (K Pcs)
Table 54. Global Glucosylceramidase Revenue by Application (2016-2021e) & (USD Million)
Table 55. Global Glucosylceramidase Revenue by Application (2021-2026) & (USD Million)
Table 56. Global Glucosylceramidase Price by Application (2016-2021e) & (USD/Pcs)
Table 57. Global Glucosylceramidase Price by Application (2021-2026) & (USD/Pcs)
Table 58. North America Glucosylceramidase Sales by Country (2016-2021e) & (K Pcs)
Table 59. North America Glucosylceramidase Sales by Country (2021-2026) & (K Pcs)
Table 60. North America Glucosylceramidase Revenue by Country (2016-2021e) & (USD Million)
Table 61. North America Glucosylceramidase Revenue by Country (2021-2026) & (USD Million)
Table 62. North America Glucosylceramidase Sales by Type (2016-2021e) & (K Pcs)
Table 63. North America Glucosylceramidase Sales by Type (2021-2026) & (K Pcs)
Table 64. North America Glucosylceramidase Sales by Application (2016-2021e) & (K Pcs)
Table 65. North America Glucosylceramidase Sales by Application (2021-2026) & (K Pcs)
Table 66. Europe Glucosylceramidase Sales by Country (2016-2021e) & (K Pcs)
Table 67. Europe Glucosylceramidase Sales by Country (2021-2026) & (K Pcs)
Table 68. Europe Glucosylceramidase Revenue by Country (2016-2021e) & (USD Million)
Table 69. Europe Glucosylceramidase Revenue by Country (2021-2026) & (USD Million)
Table 70. Europe Glucosylceramidase Sales by Type (2016-2021e) & (K Pcs)
Table 71. Europe Glucosylceramidase Sales by Type (2021-2026) & (K Pcs)
Table 72. Europe Glucosylceramidase Sales by Application (2016-2021e) & (K Pcs)
Table 73. Europe Glucosylceramidase Sales by Application (2021-2026) & (K Pcs)
Table 74. Asia-Pacific Glucosylceramidase Sales by Region (2016-2021e) & (K Pcs)
Table 75. Asia-Pacific Glucosylceramidase Sales by Region (2021-2026) & (K Pcs)
Table 76. Asia-Pacific Glucosylceramidase Revenue by Region (2016-2021e) & (USD Million)
Table 77. Asia-Pacific Glucosylceramidase Revenue by Region (2021-2026) & (USD Million)
Table 78. Asia-Pacific Glucosylceramidase Sales by Type (2016-2021e) & (K Pcs)
Table 79. Asia-Pacific Glucosylceramidase Sales by Type (2021-2026) & (K Pcs)
Table 80. Asia-Pacific Glucosylceramidase Sales by Application (2016-2021e) & (K Pcs)
Table 81. Asia-Pacific Glucosylceramidase Sales by Application (2021-2026) & (K Pcs)
Table 82. South America Glucosylceramidase Sales by Country (2016-2021e) & (K Pcs)
Table 83. South America Glucosylceramidase Sales by Country (2021-2026) & (K Pcs)
Table 84. South America Glucosylceramidase Revenue by Country (2016-2021e) & (USD Million)
Table 85. South America Glucosylceramidase Revenue by Country (2021-2026) & (USD Million)
Table 86. South America Glucosylceramidase Sales by Type (2016-2021e) & (K Pcs)
Table 87. South America Glucosylceramidase Sales by Type (2021-2026) & (K Pcs)
Table 88. South America Glucosylceramidase Sales by Application (2016-2021e) & (K Pcs)
Table 89. South America Glucosylceramidase Sales by Application (2021-2026) & (K Pcs)
Table 90. Middle East & Africa Glucosylceramidase Sales by Country (2016-2021e) & (K Pcs)
Table 91. Middle East & Africa Glucosylceramidase Sales by Country (2021-2026) & (K Pcs)
Table 92. Middle East & Africa Glucosylceramidase Revenue by Country (2016-2021e) & (USD Million)
Table 93. Middle East & Africa Glucosylceramidase Revenue by Country (2021-2026) & (USD Million)
Table 94. Middle East & Africa Glucosylceramidase Sales by Type (2016-2021e) & (K Pcs)
Table 95. Middle East & Africa Glucosylceramidase Sales by Type (2021-2026) & (K Pcs)
Table 96. Middle East & Africa Glucosylceramidase Sales by Application (2016-2021e) & (K Pcs)
Table 97. Middle East & Africa Glucosylceramidase Sales by Application (2021-2026) & (K Pcs)
Table 98. Direct Channel Pros & Cons
Table 99. Indirect Channel Pros & Cons
Table 100. Glucosylceramidase Typical Distributors
Table 101. Glucosylceramidase Typical Customers
List of Figures
Figure 1. Glucosylceramidase Picture
Figure 2. Global Glucosylceramidase Sales Market Share by Type in 2020
Figure 3. AVRRD-02
Figure 4. LTI-291
Figure 5. NCGC-607
Figure 6. Pcgin
Figure 7. Others
Figure 8. Global Glucosylceramidase Sales Market Share by Application in 2020
Figure 9. Genetic Disorders
Figure 10. Gaucher Disease
Figure 11. Parkinson's Disease
Figure 12. Others
Figure 13. Global Glucosylceramidase Market Size, (USD Million) & (K Pcs): 2020 VS 2021 VS 2026
Figure 14. Global Glucosylceramidase Market Size and Forecast (2016-2026) & (USD Million)
Figure 15. Global Glucosylceramidase Sales (2016-2026) & (K Pcs)
Figure 16. Global Glucosylceramidase Price by Type (2016-2026) & (USD/Pcs)
Figure 17. Global Glucosylceramidase Production Capacity (2016-2026) & (K Pcs)
Figure 18. Global Glucosylceramidase Production Capacity by Geographic Region: 2020 VS 2021
Figure 19. Glucosylceramidase Market Drivers
Figure 20. Glucosylceramidase Market Restraints
Figure 21. Glucosylceramidase Market Trends
Figure 22. Global Glucosylceramidase Sales Market Share by Manufacturer in 2020
Figure 23. Global Glucosylceramidase Revenue Market Share by Manufacturer in 2020
Figure 24. Glucosylceramidase Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 25. Top 3 Glucosylceramidase Manufacturer (Revenue) Market Share in 2020
Figure 26. Top 6 Glucosylceramidase Manufacturer (Revenue) Market Share in 2020
Figure 27. Global Glucosylceramidase Sales Market Share by Region (2016-2026)
Figure 28. Global Glucosylceramidase Revenue Market Share by Region (2016-2026)
Figure 29. North America Glucosylceramidase Revenue (2016-2026) & (USD Million)
Figure 30. Europe Glucosylceramidase Revenue (2016-2026) & (USD Million)
Figure 31. Asia-Pacific Glucosylceramidase Revenue (2016-2026) & (USD Million)
Figure 32. South America Glucosylceramidase Revenue (2016-2026) & (USD Million)
Figure 33. Middle East & Africa Glucosylceramidase Revenue (2016-2026) & (USD Million)
Figure 34. Global Glucosylceramidase Sales Market Share by Type (2016-2026)
Figure 35. Global Glucosylceramidase Revenue Market Share by Type (2016-2026)
Figure 36. Global Glucosylceramidase Price by Type (2016-2026) & (USD/Pcs)
Figure 37. Global Glucosylceramidase Sales Market Share by Application (2016-2026)
Figure 38. Global Glucosylceramidase Revenue Market Share by Application (2016-2026)
Figure 39. Global Glucosylceramidase Price by Application (2016-2026) & (USD/Pcs)
Figure 40. North America Glucosylceramidase Sales Market Share by Type (2016-2026)
Figure 41. North America Glucosylceramidase Sales Market Share by Application (2016-2026)
Figure 42. North America Glucosylceramidase Sales Market Share by Country (2016-2026)
Figure 43. North America Glucosylceramidase Revenue Market Share by Country (2016-2026)
Figure 44. United States Glucosylceramidase Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. Canada Glucosylceramidase Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Mexico Glucosylceramidase Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Europe Glucosylceramidase Sales Market Share by Type (2016-2026)
Figure 48. Europe Glucosylceramidase Sales Market Share by Application (2016-2026)
Figure 49. Europe Glucosylceramidase Sales Market Share by Country (2016-2026)
Figure 50. Europe Glucosylceramidase Revenue Market Share by Country (2016-2026)
Figure 51. Germany Glucosylceramidase Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. France Glucosylceramidase Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. United Kingdom Glucosylceramidase Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Russia Glucosylceramidase Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Italy Glucosylceramidase Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Asia-Pacific Glucosylceramidase Sales Market Share by Region (2016-2026)
Figure 57. Asia-Pacific Glucosylceramidase Sales Market Share by Application (2016-2026)
Figure 58. Asia-Pacific Glucosylceramidase Sales Market Share by Region (2016-2026)
Figure 59. Asia-Pacific Glucosylceramidase Revenue Market Share by Region (2016-2026)
Figure 60. China Glucosylceramidase Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Japan Glucosylceramidase Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Korea Glucosylceramidase Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. India Glucosylceramidase Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Southeast Asia Glucosylceramidase Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Australia Glucosylceramidase Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. South America Glucosylceramidase Sales Market Share by Type (2016-2026)
Figure 67. South America Glucosylceramidase Sales Market Share by Application (2016-2026)
Figure 68. South America Glucosylceramidase Sales Market Share by Country (2016-2026)
Figure 69. South America Glucosylceramidase Revenue Market Share by Country (2016-2026)
Figure 70. Brazil Glucosylceramidase Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Argentina Glucosylceramidase Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Middle East & Africa Glucosylceramidase Sales Market Share by Type (2016-2026)
Figure 73. Middle East & Africa Glucosylceramidase Sales Market Share by Application (2016-2026)
Figure 74. Middle East & Africa Glucosylceramidase Sales Market Share by Country (2016-2026)
Figure 75. Middle East & Africa Glucosylceramidase Revenue Market Share by Country (2016-2026)
Figure 76. Turkey Glucosylceramidase Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. Egypt Glucosylceramidase Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. Saudi Arabia Glucosylceramidase Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. South Africa Glucosylceramidase Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
Figure 81. Methodology
Figure 82. Research Process and Data Source
世界のゴーシェ病治療薬市場 2021：企業別、地域別、種類・用途別 The Gaucher Disease Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulatio…- 世界の消費者直結性病気リスク・健康遺伝子検査市場 2021：企業別、地域別、種類・用途別 The Direct-to-consumer Disease Risk and Health Genetic Test market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value c…
- 世界の慢性腎臓病–ミネラル・骨疾患（CKD-MBD）市場 2021：企業別、地域別、種類・用途別 The Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, val…
- 世界の病気リスク・健康DNA検査市場 2021：企業別、地域別、種類・用途別 The Disease Risk and Health DNA Test market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trad…
- 世界の消費者直結性病気リスク・健康DNA検査市場 2021：企業別、地域別、種類・用途別 The Direct-to-consumer Disease Risk and Health DNA Test market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain…